Search results
Iris Clothings Share: 174 Percent Return in 3 Years, Company Signs Agreement with Disney
Latest India News· 3 hours agoRecent survey suggested that the Indian kid apparel market is expected to grow at 9.1 % CAGR between...
Eli Lilly to buy bowel disease drug developer Morphic for $3.2 bln - ET HealthWorld | Pharma
The Economic Times· 10 hours agoLondon: Eli Lilly will acquire Morphic Holding for $3.2 billion in cash, the companies said on...
DTH companies lose over 3 million users in FY24 - ET Telecom
The Economic Times· 20 hours agoDTH Companies: The Indian DTH industry, comprising four private and one government-owned operator,...
Bengaluru Peripheral Ring Road Plan: BDA May Split Project Cost into 3; What Went Wrong?
Times Now· 8 hours ago1) BDA to split the project of Peripheral Ring Road into three to attract more bidders. 2) The cost...
Premium valuation of defence companies should sustain 3-5 years down the line: Binod Modi
The Economic Times· 20 hours agoBinod Modi, Portfolio Manager, Sharekhan, BNP Paribas, says while defence stocks should do well, in...
...July, 2024: Oil & Natural Gas Corporation, ITC, Divis Laboratories, Titan Company among most...
Livemint· 12 hours agoTop Gainers and Losers Today : The Sensex lost 36.22 points, or -0.05, to settle at 79996.6, while...
Grifols says founding family, Brookfield looking to delist drugmaker
Livemint· 33 minutes agoGrifols said its board held an extraordinary meeting over the weekend to study a preliminary offer presented by Brookfield and the Grifols founding family, which holds a stake of around 30%, ...
Consumer goods companies see ‘steady’ demand trends in Q1 | Mint
Livemint· 9 hours agoIn its quarterly update released late last week Marico Ltd said the company's domestic business...
Titan Slips 4% After Weak Q1 Update Leads To Target Price Cuts; Here's What Analysts Say - News18
News18· 15 hours agoTitan Share Price Today: Shares of Titan Company dipped 4 per cent to Rs 3,138.10 on the BSE in...
Lilly beefs up bowel disease drug portfolio with $3.2 billion Morphic deal, says report - CNBC TV18
CNBC TV18· 3 hours agoLilly counts its IBD drug, Omvoh, among its future growth drivers, besides its blockbuster weight...